Credit: Unsplash/CC0 Public Domain
A new study LED by UCLA Health Highlights The Link Between Socioeconomic Disadvantage, Medicaid Insurance, and Porer Survival Rates after Heart Transplantation.
Researchers found that medicine M Survival. It has been reported that cav contributes to more than 30% of all deaths in the first five to 10 years Following Heart Transplantation.
The study, which included Heart Transplant Recipients aged 18 and older, divided into medicine and non-medicaid cohorts, and pre -nd post-defordable Care Act (ACA) ad a higher likelihood of developing cav over Five years, with WorsE Survival Rates, Particularly in the Post-ACA Era.
It is published in The annals of thoracic surgery And will be presented at the Plenary Session of The Society of Thoracic Surgeons (STS) Annual Meeting As the top paper on perioporative and critical care.
“Cav is a Leading Cause of Morbidity and Mortality Following a Heart Transplant. Our work demonstrates that Socioeconomic Disadvantage Influences The Risk of Cav in the Months and Years Following Operation Aid Sara Sakowitz, A Medical Student at the David Geffen School of Medicine at Ucla and First Author of the Study.
“Although the Aca has expanded access to heart transplantation , High-Quality Care Remain. “
Notable, the study found that the risk of developing cav was mitigated with treatment at high-Volume transplant centers. While Medicaid Patients at Non-High-Volume Centers Had a Significly Higher Risk of Developing Cav, at High-Volume Centers the Risk for Medicaid Patients was similer to three.
Several Factors Contribute to Why Patients at High-Volume Transplant Centers Fared Better. “Patients Treated at High-Volume Transplant Centers often Benefit from Specialized Expertise, Comprehensive Care, and Robust Patint Support Systems,” Said Peyman Benharash, A On at UCLA Health, Director of the ECMO Program and Corresponding Author of the study.
“These centers are equipped with dedicated teams and streamlined protocols that ensure consistent follow-up and access to essential medicines, significantly improving post-transplant “
More information:
Insurance-Based Disparities in Cardiac Allograft Vasculopathy Following Heart Transplantation are Medived by Care at High Volume Centers, The annals of thoracic surgery (2025).
Citation: Medicaid-Insured Heart Transplant Patients Face Higher Risk of Post-Transplant Complications, Study Finds (2025, 20, January 24) Retrie 24 2025 from
This document is Subject to copyright. Apart from any Fair Dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
(Tagstotranslate) Medicine Research News (T) Medicine Research (T) Health Research News (T) Health Research (T) Health Science (T) Medicine Science
